Eurofins Scientific SE (Eurofins Scientific SE) Interest Expense : $-141 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Eurofins Scientific SE Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Eurofins Scientific SE's interest expense for the six months ended in Dec. 2023 was $ -77 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was $-141 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Eurofins Scientific SE's Operating Income for the six months ended in Dec. 2023 was $ 240 Mil. Eurofins Scientific SE's Interest Expense for the six months ended in Dec. 2023 was $ -77 Mil. Eurofins Scientific SE's Interest Coverage for the quarter that ended in Dec. 2023 was 3.13. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Eurofins Scientific SE Interest Expense Historical Data

The historical data trend for Eurofins Scientific SE's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurofins Scientific SE Interest Expense Chart

Eurofins Scientific SE Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-108.33

-126.03

-107.35

-111.86

-141.11

Eurofins Scientific SE Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Interest Expense	Get a 7-Day Free Trial															59.89	-76.22	-35.49	-64.14	-76.55

Eurofins Scientific SE Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-141 Mil.

Eurofins Scientific SE (OTCPK:ERFSF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Eurofins Scientific SE's Interest Expense for the six months ended in Dec. 2023 was $-77 Mil. Its Operating Income for the six months ended in Dec. 2023 was $240 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2023 was $3,626 Mil.

Eurofins Scientific SE's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2023 )	/	Interest Expense (Q: Dec. 2023 )
	=	-1	*	239.586	/	-76.554
	=	3.13

The higher the ratio, the stronger the company's financial strength is.

Eurofins Scientific SE (Eurofins Scientific SE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Eurofins Scientific SE (OTCPK:ERFSF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

ERFp:UK 0MV5:UK ERF:France ESF0:Germany

Address

23 Val Fleuri, Luxembourg, LUX, L-1526

Website

https://www.eurofins.com

Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 900 laboratories in 61 countries. Its revenue from Europe, North America, and the Rest of the World contribute approximately 50%, 40%, and 10% of total revenue respectively. Its main business activities are food and environmental testing, biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.